Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02222896 · ClinicalTrials.gov registry record · Phase 3
Preoperative Chlorhexidine Gluconate (CHG) Cloth on Healthy Subjects
A Phase 3 study of Surgery, sponsored by Medline Industries.
- Completed
- Registry status
- Phase 3
- Development phase
- 347
- Enrollment target
- 1
- Study location
NCT02222896: Completed Phase 3 study of Surgery, sponsored by Medline Industries.
NCT02222896 is a Phase 3 study of Surgery that has completed, run by Medline Industries. The registered enrollment target is 347 participants, below the 52,849-participant average among 120 other Surgery trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02222896, a Phase 3 study of Surgery, has completed, sponsored by Medline Industries.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 347 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate the effects of Chlorhexidine Gluconate (CHG) cloth on the reduction of bacteria on the skin.
Primary Outcome
Percent of abdomen and groin sites that showed response (achieve a 2-Log and 3-Log reduction) respectively of bacterial flora from baseline. Note: the number of participants in each treatment group (abdomen and/or groin) can vary depending on whether participants achieved qualifying microbial levels.
Conditions Studied
Interventions
- OTHER Vehicle
- DRUG Chlorhexidine Gluconate
- DRUG DynaHex-2
Study Locations (1)
Virginia
- MBT - Sterling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 347 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-05 |
| Phase | Phase 3 |
What the finished NCT02222896 record still lists
NCT02222896 is an interventional study that assigns participants to a tested intervention. The registered 347 participants enrollment target is mid-sized for trials with a published cap, below the 52,849-participant average among 120 other Surgery trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 3 interventions - of which Vehicle is the first listed.
NCT02222896 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT02222896 about?
NCT02222896 is a clinical study titled "Preoperative Chlorhexidine Gluconate (CHG) Cloth on Healthy Subjects". Evaluate the effects of Chlorhexidine Gluconate (CHG) cloth on the reduction of bacteria on the skin.
What is the current status of trial NCT02222896?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 347 participants. The study started on 2014-08. Estimated completion is 2015-05.
What conditions does trial NCT02222896 study?
This clinical trial studies the following conditions: Surgery.
What interventions are being tested in trial NCT02222896?
The interventions under investigation include: Vehicle (OTHER), Chlorhexidine Gluconate (DRUG), DynaHex-2 (DRUG).
Who is sponsoring clinical trial NCT02222896?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02222896 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02222896's enrollment target sits among peer trials
347 28th of 120 higher than 93 of 120 other Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NO During CPB in Neonates to Reduce Risk of AKI
RECRUITING · Phase 3
-
Sentinel Node Biopsy in Endometrial Cancer
RECRUITING · Phase 3
-
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
RECRUITING · Phase 3
-
The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial
ACTIVE NOT RECRUITING · Phase 3
-
Evaluating Outcomes in Cardiac Surgery Patients Who Receive Sugammadex vs. Placebo
ACTIVE NOT RECRUITING · Phase 3
-
Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01742143 · 347 participants
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
- NCT04877522 · 347 participants · Phase 4
Asciminib Roll-over Study
- NCT05834660 · 347 participants · NA
SAFETY-A for Promoting Equity in Suicide Prevention Outcomes in Schools
- NCT06963827 · 347 participants · Phase 3
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia